156 related articles for article (PubMed ID: 36526544)
1. Clinical and epilepsy characteristics in Wolf-Hirschhorn syndrome (4p-): A review.
Paprocka J; Kaminiów K; Yetkin O; Tekturk P; Baykan B; Leiz S; Kluger G; Striano P
Seizure; 2024 Mar; 116():14-23. PubMed ID: 36526544
[TBL] [Abstract][Full Text] [Related]
2. On the nosology and pathogenesis of Wolf-Hirschhorn syndrome: genotype-phenotype correlation analysis of 80 patients and literature review.
Zollino M; Murdolo M; Marangi G; Pecile V; Galasso C; Mazzanti L; Neri G
Am J Med Genet C Semin Med Genet; 2008 Nov; 148C(4):257-69. PubMed ID: 18932124
[TBL] [Abstract][Full Text] [Related]
3. From Wolf-Hirschhorn syndrome to NSD2 haploinsufficiency: a shifting paradigm through the description of a new case and a review of the literature.
Wiel LC; Bruno I; Barbi E; Sirchia F
Ital J Pediatr; 2022 May; 48(1):72. PubMed ID: 35550183
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of epilepsy and electroencephalogram patterns in Wolf-Hirschhorn syndrome: experience with 87 patients.
Battaglia A; Filippi T; South ST; Carey JC
Dev Med Child Neurol; 2009 May; 51(5):373-80. PubMed ID: 19379291
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Antiseizure Medications in Wolf-Hirschhorn Syndrome.
Horiguchi A; Koichihara R; Kikuchi K; Nonoyama H; Daida A; Oba D; Hirata Y; Matsuura R; Ohashi H; Hamano SI
Neuropediatrics; 2023 Oct; 54(5):339-343. PubMed ID: 37075791
[TBL] [Abstract][Full Text] [Related]
6. Natural history study of adults with Wolf-Hirschhorn syndrome 2: Patient-reported outcomes study.
Carey JC; Lortz A; Mendel A; Battaglia A
Am J Med Genet A; 2021 Jul; 185(7):2065-2069. PubMed ID: 33949758
[TBL] [Abstract][Full Text] [Related]
7. Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome: experience with 87 patients and recommendations for routine health supervision.
Battaglia A; Filippi T; Carey JC
Am J Med Genet C Semin Med Genet; 2008 Nov; 148C(4):246-51. PubMed ID: 18932224
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal microarray testing identifies a 4p terminal region associated with seizures in Wolf-Hirschhorn syndrome.
Ho KS; South ST; Lortz A; Hensel CH; Sdano MR; Vanzo RJ; Martin MM; Peiffer A; Lambert CG; Calhoun A; Carey JC; Battaglia A
J Med Genet; 2016 Apr; 53(4):256-63. PubMed ID: 26747863
[TBL] [Abstract][Full Text] [Related]
9. Natural history study of adults with Wolf-Hirschhorn syndrome 1: Case series of personally observed 35 individuals.
Battaglia A; Lortz A; Carey JC
Am J Med Genet A; 2021 Jun; 185(6):1794-1802. PubMed ID: 33760347
[TBL] [Abstract][Full Text] [Related]
10. Epilepsy in Wolf-Hirschhorn syndrome (4p-).
Kagitani-Shimono K; Imai K; Otani K; Kamio N; Okinaga T; Toribe Y; Suzuki Y; Ozono K
Epilepsia; 2005 Jan; 46(1):150-5. PubMed ID: 15660782
[TBL] [Abstract][Full Text] [Related]
11. Microarray and FISH-based genotype-phenotype analysis of 22 Japanese patients with Wolf-Hirschhorn syndrome.
Shimizu K; Wakui K; Kosho T; Okamoto N; Mizuno S; Itomi K; Hattori S; Nishio K; Samura O; Kobayashi Y; Kako Y; Arai T; Tsutomu OI; Kawame H; Narumi Y; Ohashi H; Fukushima Y
Am J Med Genet A; 2014 Mar; 164A(3):597-609. PubMed ID: 24357569
[TBL] [Abstract][Full Text] [Related]
12. Wolf-Hirschhorn syndrome: A case series from India.
Chaudhry C; Kaur A; Panigrahi I; Kaur A
Am J Med Genet A; 2020 Dec; 182(12):3048-3051. PubMed ID: 32914558
[TBL] [Abstract][Full Text] [Related]
13. Unusual 4p16.3 deletions suggest an additional chromosome region for the Wolf-Hirschhorn syndrome-associated seizures disorder.
Zollino M; Orteschi D; Ruiter M; Pfundt R; Steindl K; Cafiero C; Ricciardi S; Contaldo I; Chieffo D; Ranalli D; Acquafondata C; Murdolo M; Marangi G; Asaro A; Battaglia D
Epilepsia; 2014 Jun; 55(6):849-57. PubMed ID: 24738919
[TBL] [Abstract][Full Text] [Related]
14. Molecular and clinical characterization of a patient with a chromosome 4p deletion, Wolf-Hirschhorn syndrome, and congenital glaucoma.
Finzi S; Pinto CF; Wiggs JL
Ophthalmic Genet; 2001 Mar; 22(1):35-41. PubMed ID: 11262648
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic significance of deletions distal to the currently described Wolf-Hirschhorn syndrome critical regions on 4p16.3.
South ST; Hannes F; Fisch GS; Vermeesch JR; Zollino M
Am J Med Genet C Semin Med Genet; 2008 Nov; 148C(4):270-4. PubMed ID: 18932125
[TBL] [Abstract][Full Text] [Related]
16. Epilepsy in a child with Wolf-Hirschhorn syndrome.
Mitić V; Cuturilo G; Novaković I; Dimitrijević N; Damnjanović T; Dimitrijević A; Dobricić V; Kostić V; Radlović N
Srp Arh Celok Lek; 2011; 139(11-12):795-9. PubMed ID: 22338478
[TBL] [Abstract][Full Text] [Related]
17. Mouse models for the Wolf-Hirschhorn deletion syndrome.
Näf D; Wilson LA; Bergstrom RA; Smith RS; Goodwin NC; Verkerk A; van Ommen GJ; Ackerman SL; Frankel WN; Schimenti JC
Hum Mol Genet; 2001 Jan; 10(2):91-8. PubMed ID: 11152656
[TBL] [Abstract][Full Text] [Related]
18. Distinct Epileptogenic Mechanisms Associated with Seizures in Wolf-Hirschhorn Syndrome.
Corrêa T; Mayndra M; Santos-Rebouças CB
Mol Neurobiol; 2022 May; 59(5):3159-3169. PubMed ID: 35278209
[TBL] [Abstract][Full Text] [Related]
19. Risk of hepatic neoplasms in Wolf-Hirschhorn syndrome (4p-): Four new cases and review of the literature.
Battaglia A; Calhoun ARUL; Lortz A; Carey JC
Am J Med Genet A; 2018 Nov; 176(11):2389-2394. PubMed ID: 30289612
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
